Xenglu Lin 10/5mg Tablet – Dual-Action Empagliflozin + Linagliptin
Xenglu Lin 10/5mg Tablet – Dual-Action Empagliflozin + Linagliptin
Xenglu Lin 10/5mg Tablet – Dual-Action Empagliflozin + Linagliptin
Description
Xenglu Lin 10/5mg Tablet – Powerful SGLT2 + DPP-4 Combination for Superior Glycemic & Cardio Protection
Xenglu Lin 10/5mg Tablet combines empagliflozin 10mg (SGLT2 inhibitor) and linagliptin 5mg (DPP-4 inhibitor) in a single once-daily pill to deliver complementary mechanisms: empagliflozin removes excess glucose through urine while linagliptin boosts insulin release and lowers glucagon levels. This proven dual therapy provides stronger A1C reduction than either drug alone, promotes modest weight loss, lowers blood pressure, and offers significant cardiovascular and kidney protection—ideal for adults with type 2 diabetes who need enhanced control beyond metformin or single-agent therapy.
